Matthew M Heeney

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Venues

Pediatric blood & cancer

Blood

American journal of hematology

Blood advances

Trinity College, University of Toronto (BSC)

This page only lists publications with an associated author ORCID identifier.

Education History

Trinity College, University of Toronto Sep 01 1988 - May 01 1992

Canada

BSC :: Immunology

Publications

Jeffrey G Edwards, Adam Paul Yan, Ramy Yim, Mo Oni, Matthew M Heeney, Dave Johnson, Chris I Wong, Maya Ilowite, Natasha M Archer
Sustained increase in annual transcranial Doppler screening rates in children with sickle cell disease: A quality improvement project. Pediatric blood & cancer 71 (8) (2024)
Jeffrey G Edwards, Adam Paul Yan, Ramy Yim, Mo Oni, Matthew M Heeney, Dave Johnson, Chris I Wong, Maya Ilowite, Natasha M Archer
Sustained increase in annual transcranial Doppler screening rates in children with sickle cell disease: A quality improvement project. Pediatric blood & cancer (2024)
Jeffrey G Edwards, Adam Paul Yan, Ramy Yim, Mo Oni, Matthew M Heeney, Dave Johnson, Chris I Wong, Maya Ilowite, Natasha M Archer
Sustained increase in annual transcranial Doppler screening rates in children with sickle cell disease: A quality improvement project. Pediatric blood & cancer 71 (8) (2024)
Monica L Hulbert, Deepa Manwani, Emily Riehm Meier, Ofelia A Alvarez, R Clark Brown, Michael U Callaghan, Andrew D Campbell, Thomas D Coates, Melissa J Frei-Jones, Jane Silva Hankins, Matthew M Heeney, Lewis Li-Yen Hsu, Jeffrey D Lebensburger, Charles T Quinn, Nirmish Shah, Kim Smith-Whitley, Courtney Dawn Thornburg, Julie Kanter
Consensus definition of essential, optimal, and suggested components of a pediatric sickle cell disease center. Pediatric blood & cancer 70 (1) (2022)
Matthew M Heeney, Miguel R Abboud, Jessie Githanga, Baba Psalm Duniya Inusa, Julie Kanter, Alan D Michelson, Videlis Nduba, Victor Musiime, Mohini Apte, Adlette Inati, Amar M Taksande, Marielle Andersson, Magnus Åstrand, Noha Maklad, Mohammad Niazi, Anders Himmelmann, Anders R Berggren
Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study. Blood 140 (13) (2022)
Emily M Harris, Emily Vilk, Matthew M Heeney, Jean Solodiuk, Christine Greco, Natasha M Archer
A systematic review of ketamine for the management of vaso-occlusive pain in sickle cell disease. Pediatric blood & cancer 68 (7) (2021)
Ahmed A Daak, Carlton D Dampier, Beng Fuh, Julie Kanter, Ofelia A Alvarez, L Vandy Black, Melissa A McNaull, Michael U Callaghan, Alex George, Lynne Neumayr, Lee M Hilliard, Fredrick Sancilio, Adrian L Rabinowicz, Matthew M Heeney
Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial). Blood advances 2 (15) (2019)
Samir K Ballas, Amer M Zeidan, Vu H Duong, Michelle DeVeaux, Matthew M Heeney
The effect of iron chelation therapy on overall survival in sickle cell disease and β-thalassemia: A systematic review. American journal of hematology 93 (7) (2018)
Matthew M Heeney, Dongjing Guo, Luigia De Falco, Dean R Campagna, Gordana Olbina, Paige P-C Kao, Klaus Schmitz-Abe, Fedik Rahimov, Patrick Gutschow, Keith Westerman, Vaughn Ostland, Tracy Jackson, Robert J Klaassen, Kyriacos Markianos, Karin E Finberg, Achille Iolascon, Mark Westerman, Wendy B London, Mark Daniel Fleming
Normalizing hepcidin predicts TMPRSS6 mutation status in patients with chronic iron deficiency. Blood 132 (4) (2018)

Matthew M Heeney.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Matthew M Heeney